Research Article
Mycobacterium tuberculosis Infection following Kidney Transplantation
Table 4
Anti-TB treatment and course of patients.
| Name | Duration of ttt TB treatment (months) | Course | Recurrence of TB | Interval between stop of TB ttt and recurrence | Duration of resumption of antiTB treatment (months) | Followup (months) | Course |
| (1) A M | 6 | ARF, DCG loss of graft | Lumbar pain and radiologic abnormalities | | 12 | 9,363 | HD | (2) A H | 12 | Hepatotoxicity hyperuricemia | Lymph nodes TB | | 12 | 213,717 | Recovery | (3) Z A | 12 | ARF CAD | — | | — | 11,992 | HD | (4) Gh N | 12 | — | Meningeal and vertebral TB after stop of ttt | | — | 23,918 | Death | (5) D Y | 10 | ARF, CAD | — | | — | 26,809 | CAD | (6) H O | 12 | — | — | | — | 1,150 | Recovery | (7) D M | 6 | Hepatotoxicity | Lymph nodes TB, 6 months after stop of ttt | | 12 | 149,881 | Recovery | (8) H A | 12 | ARF | — | | — | 20,337 | Recovery | (9) M A | 10 | Hepatotoxicity Hyperuricemia | — | | — | 58,251 | Recovery | (10) M F | 1 | CAD | — | | — | 1,577 | Death | (11) H Dh | 9 | — | — | | — | 9,626 | Recovery | (12) M A | 12 | Hyperuricemia | — | | — | 16,657 | Recovery | (13) J K | 12 | ARF CAD | — | | — | 35,055 | CAD | (14) Ch N | 12 | CAD | — | | — | 47,441 | HD | (15) B F | 17 | ARF | — | | — | 173,602 | Recovery | (16) J H | 10 | Hyperuricemia ARF CAD | — | | — | 18,201 | HD |
|
|
ARF: acute renal failure, AR: acute rejection, CAD: chronic allograft dysfunction, HD: hemodialysis, ttt: TB treatment, TB: tuberculosis.
|